Parvo preventative picks up speedDecember 29, 2020Elanco Animal Health is set to acquire the global rights to Kindred Biosciences’ proprietary KIND-030, a monoclonal antibody being developed for the treatment and prevention of canine parvovirus.
Education Center - SponsoredAlternative therapies for improving quality of life in senior petsby • VetriScience Pro LineAdvances in veterinary medicine and animal nutrition have resulted in pets living longer than ever before. That leaves an increasing number of cats and dogs prone to common age-related problems.
